M23 SAYS HUNDREDS OF BURUNDI SOLDIERS CAPTURED IN LATEST CONGO OFFENSIVE. (PHOTO).

Image
 M23 says hundreds of Burundi soldiers captured in latest Congo offensive The Rwanda-backed M23 group has captured hundreds of Burundian soldiers during its latest offensive in eastern Democratic Republic of Congo, a rebel official said, as clashes continued despite a warning from the Trump administration. Last week M23 entered the strategic town of Uvira near the border with Burundi, less than a week after the presidents of Congo and Rwanda met in Washington with U.S. President Donald Trump and affirmed their commitment to a peace deal known as the Washington Accords. U.S. Secretary of State Marco Rubio said on Saturday that Rwanda's actions in eastern Congo violated the Washington Accords and vowed to "take action to ensure promises made to the President are kept". Rwanda denies supporting M23 and has blamed Congolese and Burundian forces for the renewed fighting. A United Nations group of experts report published in July said Rwanda exercised command and control over t...

CHINESE COVID-19 VACCINE SHOWS PROMISING RESULTS.[PHOTO}.

Chinese COVID-19 vaccine shows promising results - CGTN
   We are all expecting a COVID-19 vaccine that could possibly end the pandemic that has killed more than 330,000 people.
Now the first vaccine candidate from China has finished its phase-1 trial on humans, and the results have been put online for everyone to examine.
The Lancet, a respected medical journal in the UK, published the results on Friday saying it is "safe" and "induces rapid immune response."
The research injected the potential vaccine into 108 volunteers.
They were divided into three groups, each taking a different dose of the vaccine.
The vaccine, classified as "recombinant adenovirus type-5 vectored" (Ad5-nCoV), acts as a natural infection and is especially good at teaching the immune system how to fight the virus.During the next 28 days, no serious reactions were found, meaning the vaccine seemed to be tolerable by humans.Also, antibodies against the SARS-CoV-2 started to surge two weeks after the injection and reached its peak on day 28.The vaccine "warrants further investigation," the paper on The Lancet concluded.A phase-2 clinical trial has started with 508 volunteers involved.The trial was conducted by a team led by Chen Wei, a biology professor from Academy of Military Medical Sciences and a member of the Chinese Academy of Engineering.There are other two vaccines allowed for human trials in China. They are ShaCoVacc and PiCoVacc.-CCTV.
Chinese COVID-19 vaccine shows promising results - CGTN

Comments

Popular posts from this blog

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).

THE NEW OONI OF ILE-IFE,WILL NOT EAT THE HEART OF THE LATE OONI-PALACE CHIEFS.